Showing 6361-6370 of 20920 results for "".
- Pilocarpine Drops and Glaucoma Medication Reduction in Post-Goniotomy Carehttps://reachmd.com/news/pilocarpine-drops-and-glaucoma-medication-reduction-in-post-goniotomy-care/2474250/In the evolving landscape of glaucoma treatment, recent investigations into post-operative care are casting new light on a century-old medication—pilocarpine. Traditionally used to manage intraocular pressure (IOP) through its miotic effects, pilocarpine is now gaini
- Women's Cardiovascular Risk: AI-QCT in Enhanced Detection and Stratificationhttps://reachmd.com/news/womens-cardiovascular-risk-ai-qct-in-enhanced-detection-and-stratification/2474293/In a pivotal advancement for cardiovascular medicine, recent clinical trials have revealed that artificial intelligence-supported quantitative computed tom
- The Role of 3D Gene Architecture in Glioblastomahttps://reachmd.com/news/the-role-of-3d-gene-architecture-in-glioblastoma/2474273/This article investigates the association between the three-dimensional folding of DNA within brain cells and glioblastoma. Leveraging preclinical research from Weill Cornell Medicine, it examines the impact of disruptions in 3D gene hubs on cellular functions.
- Hearing Loss and Dementia: Exploring the Link in Older Adultshttps://reachmd.com/news/hearing-loss-and-dementia-exploring-the-link-in-older-adults/2474287/As the global population ages, the rising prevalence of dementia has galvanized efforts to identify modifiable risk factors that could delay or prevent cognitive decline. One of the most promising yet underappreciated contributors to dementia risk is hearing loss. O
- Comprehensive Motion Management: MR-linac Applications in Prostate Cancer Radiotherapyhttps://reachmd.com/news/comprehensive-motion-management-mr-linac-applications-in-prostate-cancer-radiotherapy/2474278/Recent advancements in radiotherapy have introduced the 1.5T MR-linac, a novel device that merges magnetic resonance imaging with real-time radiation delivery. This dual-capability system represents a major stride toward precision medicine in prostate cancer care, allowing clinicians to visualize
- Clinical Data on Lumenis’ New Laser Hair Removal Solution to Be Presented at ASLMS Conferencehttps://reachmd.com/news/new-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2475349/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® tec
- AI Algorithm and Hypertrophic Cardiomyopathy: Enhanced Risk Stratification in Cardiologyhttps://reachmd.com/news/ai-algorithm-and-hypertrophic-cardiomyopathy-enhanced-risk-stratification-in-cardiology/2474276/Recent developments in artificial intelligence are transforming the landscape of hypertrophic cardiomyopathy management. By swiftly pinpointing high-risk individuals and seamlessly incorporating risk assessments into clinical routines, AI enables personalized and efficient
- Bliss Aesthetics Raises $17.5M to Launch AI-Powered Cosmetic Surgery Platformhttps://reachmd.com/news/bliss-aesthetics-raises-175m-to-launch-ai-powered-cosmetic-surgery-platform/2474271/Bliss Aesthetics, a digital platform that uses artificial intelligence (AI) to connect patients with board-certified plastic surgeons, announced a $17.5 million seed funding round. The investment, led by Shine Capital with participation from Synchrony Ventures, Sheva Ventures, Point72 Ve
- Clinical Data on Lumenis’ New Laser Hair Removal Solution Presented at ASLMS Conferencehttps://reachmd.com/news/clinical-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2474269/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® tec
- Team-Based Primary Care: A Frontline Strategy for Opioid Use Disorderhttps://reachmd.com/news/team-collaboration-in-primary-care-enhancing-treatment-for-opioid-use-disorder/2474257/In the evolving landscape of opioid use disorder (OUD) treatment, primary care is no longer a peripheral player. It’s becoming a central battleground. At the heart of this shift is a transformation in how care is delivered—not by individuals working in silos, but b